Accuracy of FNAC in Diagnosis of Thyroid Nodules

Launched by ASSIUT UNIVERSITY · Jan 17, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how accurate a test called Fine Needle Aspiration Cytology (FNAC) is for diagnosing thyroid nodules. Thyroid nodules are lumps that can form in the thyroid gland, and the FNAC test helps doctors decide whether these nodules are benign (not harmful) or cancerous. The trial is seeking participants who have thyroid issues, specifically those with either a single nodule or multiple nodules that have been identified as potentially concerning by an ultrasound. To be eligible, participants should be fit for surgery and range in age from 10 to 80 years old.

If you decide to participate, you will undergo the FNAC test, which involves using a thin needle to take a sample from the nodule for testing. Afterward, if necessary, you may have surgery to further investigate or treat the nodule. It’s important to note that this trial is not yet recruiting participants, and those with other health conditions that make them unfit for surgery will not be included. This study aims to improve the understanding of how well FNAC can help in diagnosing thyroid nodules, which could lead to better care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. thyroid disease
• • 2. multinodular
• • 3. single nodule
• • 4. TIRAD 3 or more by US
• • 5. thyroid disease underwent FNAC then surgery
• • 6. all age groups
• • 7. patient fit for surgery
• Exclusion Criteria:
• • 1. patients with comorbidities.
• • 2. patients unfit for surgery
• • 3. patients who refused surgery.
• • 4. Patient with no diagnostic FNAC.